Cancelling COVID

  • Post author:

Healthcare will continue to be on interest to investors.

Pfizer & BioNTech

After France and Spain, the U.K. has the next largest number of coronavirus cases in Europe.

The U.K. is the first to approve the coronavirus vaccine and grant emergency approval to Pfizer and BioNTech and will now see other countries follow soon.

Regulators in the U.S. and Europe are yet to decide on granting emergency use of the vaccine.

U.K. has an agreement for 40 mln doses which will cover about 33% of the population as two doses are required per person.

The markets are depending on the recovery of economies and normality returning, be it a possible new normal.

Based on that, Healthcare and Tech are the two sectors still in focus. Meaning, we are still not seeing a real rotation out of tech.

Let’s go trade!